SWOG clinical trial number
SWOG-8406
Evaluation of Esorubicin (4'Deoxydoxorubicin)(NSC- 267469) in Malignant Lymphoma
Closed
Phase
Published
Abbreviated Title
Evaluation of Esorubicin (4'Deoxydoxorubicin)(NSC- 267469) in Malignant Lymphoma
Activated
08/17/1984
Closed
03/15/1988
Publication Information Expand/Collapse
1991
Activity of esorubicin in recurrent malignant lymphoma: A Southwest Oncology Group study.